HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minimally invasive percutaneous nephrolithotomy for upper urinary tract calculi in transplanted kidneys.

AbstractOBJECTIVE:
To report our experience with minimally invasive percutaneous nephrolithotomy (mPCNL) for upper urinary tract (UUT) calculi in transplanted kidneys.
PATIENTS AND METHODS:
Between August 2002 and June 2006, seven patients (mean age 40.7 years) with UUT stones in transplanted kidneys (including one staghorn, two pelvic and four ureteric stones) were treated by mPCNL. A 16 F peel-away sheath was placed as the percutaneous access port and a 8.5/11.5 F nephroscope or a 8/9.8 F ureteroscope was used for manipulation. Every 2-3 months during the follow-up, patients had their serum urea, creatinine and uric acid measured, with urine culture and ultrasonography.
RESULTS:
All patients were rendered stone-free at one mPCNL procedure, with no complications during or after surgery. The mean (range) operative duration was 53 (20-100) min and the mean haemoglobin decrease was 0.55 (0.2-1.2) g/dL. At a mean (range) follow-up of 23 (3-48) months renal allograft function was stable in all patients and no recurrence of stone was detected.
CONCLUSIONS:
mPCNL is safe and effective for managing calculi in transplanted kidneys, and it can be the initial therapy for most cases of UUT stones in transplanted kidneys, except for simple and small stones in the middle or lower calyx.
AuthorsZhaohui He, Xun Li, Lizhong Chen, Guohua Zeng, Jian Yuan
JournalBJU international (BJU Int) Vol. 99 Issue 6 Pg. 1467-71 (Jun 2007) ISSN: 1464-4096 [Print] England
PMID17309551 (Publication Type: Journal Article)
Topics
  • Adult
  • Female
  • Humans
  • Kidney Calculi (surgery)
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Nephrostomy, Percutaneous (adverse effects, methods)
  • Recurrence
  • Risk Factors
  • Treatment Outcome
  • Ureteral Calculi (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: